Literature DB >> 12776275

Hypouricemia in individuals admitted to an inpatient hospital-based facility.

Eleni T Bairaktari1, Anna I Kakafika, Nikos Pritsivelis, Katerina G Hatzidimou, Epameinondas V Tsianos, Konstantin I Seferiadis, Moses S Elisaf.   

Abstract

BACKGROUND: Decreased serum uric acid levels resulting from renal urate wasting occasionally are reported in hospitalized patients because of isolated or generalized proximal tubular damage. There are limited recent findings with regard to the incidence and cause of hypouricemia in patients admitted to an internal medicine clinic. The aim of this study is to examine the prevalence of hypouricemia in individuals admitted to our inpatient hospital-based facility and identify underlying causes and pathogenetic mechanisms and any association of hypouricemia and uricosuria with other tubular defects.
METHODS: A total of 7,250 serum urate measurements were available on patients' admission. Hypouricemia is defined as a serum urate level less than 2.5 mg/dL (149 micromo/L). In all hypouricemic cases, a detailed clinical and laboratory investigation was performed.
RESULTS: Hypouricemia was found in 90 patients (1.24%). In all except one patient, hypouricemia was associated with inappropriate uricosuria (urate fractional excretion [FE] > 10%; range, 10.8% to 94%). There was an inverse correlation between serum uric acid level and its FE (r = -0.73; P < 0.0001). The most common causes of hypouricemia were obstructive jaundice of any cause (n = 18), solid or hematologic neoplasias (n = 17), diabetes mellitus (n = 12), drugs affecting urate homeostasis (n = 10), and intracranial diseases (n = 8). Seventeen patients with hypouricemia showed one or more other manifestations of proximal tubular damage, such as glucosuria, inappropriate phosphaturia leading to hypophosphatemia, and kaliuria resulting in hypokalemia.
CONCLUSION: Hypouricemia caused by inappropriate uricosuria is not rare in patients admitted to an internal medicine clinic, is related to underlying diseases, and may be associated with other abnormalities of proximal tubular function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776275     DOI: 10.1016/s0272-6386(03)00355-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Gout, diuretics and the kidney.

Authors:  E Pascual; M Perdiguero
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

2.  Mutational analysis of idiopathic renal hypouricemia in Korea.

Authors:  Hae Il Cheong; Ju Hyung Kang; Joo Hoon Lee; Il Soo Ha; Suhnggwon Kim; Fusako Komoda; Takashi Sekine; Takashi Igarashi; Yong Choi
Journal:  Pediatr Nephrol       Date:  2005-05-24       Impact factor: 3.714

Review 3.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

4.  Serum Uric Acid Revealed a U-Shaped Relationship With All-Cause Mortality and Cardiovascular Mortality in High Atherosclerosis Risk Patients: The ASSURE Study.

Authors:  Yan Cang; Shaojie Xu; Jingyin Zhang; Jingyi Ju; Zijun Chen; Keke Wang; Jue Li; Yawei Xu
Journal:  Front Cardiovasc Med       Date:  2021-05-24

5.  Clinical and functional characterization of URAT1 variants.

Authors:  Velibor Tasic; Ann Marie Hynes; Kenichiro Kitamura; Hae Il Cheong; Vladimir J Lozanovski; Zoran Gucev; Promsuk Jutabha; Naohiko Anzai; John A Sayer
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

6.  Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome.

Authors:  Vin-Cent Wu; Jenq-Wen Huang; Po-Ren Hsueh; Ya-Fei Yang; Hung-Bin Tsai; Wei-Chih Kan; Hong-Wei Chang; Kwan-Dun Wu
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

7.  Prevalence and possible causes of hypouricemia at a tertiary care hospital.

Authors:  Chang-Nam Son; Ji-Min Kim; Sang-Hyon Kim; Soo-Kyung Cho; Chan-Bum Choi; Yoon-Kyoung Sung; Tae-Hwan Kim; Sang-Cheol Bae; Dae-Hyun Yoo; Jae-Bum Jun
Journal:  Korean J Intern Med       Date:  2016-03-09       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.